Report Categories
View AllRecent Articles
View All
ASTH Astrana posts 11 percent Q4 2025 EPS beat shares rise modestly after earnings release
VRAX Virax outlines new infectious disease testing rollout plans to drive upcoming fiscal year growth
What Marqeta MQ bond yields suggest about risk Q4 2025 Below Expectations
NSAB National management outlines cautious capital allocation priorities amid broader market headwinds